These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6665763)

  • 1. Protective effect of warfarin in arterial thrombosis: evidence from a vascular prosthesis model in rats.
    Reyers I; de Gaetano G; Donati MB
    Thromb Haemost; 1983 Dec; 50(4):821-3. PubMed ID: 6665763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.
    De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L
    Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats.
    Chabielska E; Pawlak R; Golatowski J; Buczko W
    J Physiol Pharmacol; 1998 Jun; 49(2):251-60. PubMed ID: 9670108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of extra virgin olive oil on experimental thrombosis and primary hemostasis in rats.
    Brzosko S; De Curtis A; Murzilli S; de Gaetano G; Donati MB; Iacoviello L
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):337-42. PubMed ID: 12669681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of warfarin on thrombosis of the jugular veins of rabbits induced by prolonged stasis.
    Foschi D; Scagnol I; Radaelli E; Pace M; Trabucchi E
    Drugs Exp Clin Res; 1993; 19(4):183-8. PubMed ID: 8131714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cilostazol with warfarin as antithrombotic therapy after femoro-popliteal bypass surgery using an ePTFE graft.
    Ohtake H; Urayama H; Kimura K; Yokoi K; Tsunezuka Y; Kawakami T; Kawasuji M; Watanabe Y
    Minerva Cardioangiol; 1997 Nov; 45(11):527-30. PubMed ID: 9549283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin and heparin interaction with prostacyclin-like activity generated by arterial wall in the rat.
    Doni MG; Piva E
    Thromb Haemost; 1983 Jun; 49(3):228-9. PubMed ID: 6348997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe thrombocytopenia delays but does not prevent the occlusion of an arterial prosthesis in rats.
    Reyers I; Mussoni L; Donati MB; de Gaetano G
    Thromb Haemost; 1981 Aug; 46(2):558-60. PubMed ID: 7053224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time.
    Dogné JM; Hanson J; de Leval X; Kolh P; Tchana-Sato V; de Leval L; Rolin S; Ghuysen A; Segers P; Lambermont B; Masereel B; Pirotte B
    J Pharmacol Exp Ther; 2004 May; 309(2):498-505. PubMed ID: 14742735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the dose of warfarin for therapeutic anticoagulation.
    Sharma NK; Routledge PA; Rawlins MD; Davies DM
    Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
    Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model.
    Tanabe K; Morishima Y; Shibutani T; Terada Y; Hara T; Shinohara Y; Aoyagi K; Kunitada S; Kondo T
    Thromb Haemost; 1999 May; 81(5):828-34. PubMed ID: 10365760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term standard-dose warfarin to prevent thrombosis.
    Depenbrock PJ
    Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.